Skip to main content

ICPE 2022 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Roaa M. Alamri

Saudi Arabia

Poster(s):

(189) Appendicitis Associated with Pembrolizumab Use: Adverse Events- Signal Review
Friday, August 26, 2022
8:00 AM – 6:00 PM CEST
(190) Pancreatic Carcinoma Associated with Liraglutide Use: Adverse Events- Signal Review
Friday, August 26, 2022
8:00 AM – 6:00 PM CEST
(172) Pembrolizumab and The Potential Risk of Cholestasis: A Review of Pharmacovigilance Data
Friday, August 26, 2022
8:00 AM – 6:00 PM CEST